Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece
Authors:
Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, Michailidi C, Lowry C, Tzanetakos C and Kourlaba G.
Publication type:
Conference Proceedings – Poster
Publication Name:
Virtual ISPOR Europe 2020
Citation:
Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, Michailidi C, Lowry C, Tzanetakos C and Kourlaba G. Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece. Virtual ISPOR Europe 2020. 16-19 November 2020. Poster PCN56.